Piper Sandler Lowers Trupanion (NASDAQ:TRUP) Price Target to $52.00

Trupanion (NASDAQ:TRUP) had its price objective reduced by Piper Sandler from $57.00 to $52.00 in a note issued to investors on Thursday,Benzinga reports. The firm currently has an “overweight” rating on the financial services provider’s stock. Piper Sandler’s target price indicates a potential upside of 57.81% from the stock’s current price.

A number of other equities analysts also recently issued reports on the stock. Stifel Nicolaus lifted their price objective on shares of Trupanion from $42.00 to $44.00 and gave the stock a “hold” rating in a report on Monday, January 6th. Northland Securities boosted their price target on shares of Trupanion from $45.00 to $50.00 and gave the stock a “market perform” rating in a report on Thursday, October 31st. Two analysts have rated the stock with a hold rating, four have given a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $46.60.

Trupanion Price Performance

Shares of NASDAQ TRUP opened at $32.95 on Thursday. The stock has a market cap of $1.40 billion, a price-to-earnings ratio of -143.26, a PEG ratio of 8.29 and a beta of 1.60. The company has a debt-to-equity ratio of 0.40, a quick ratio of 1.66 and a current ratio of 1.66. Trupanion has a fifty-two week low of $19.69 and a fifty-two week high of $57.90. The firm’s 50-day simple moving average is $48.04 and its 200 day simple moving average is $47.89.

Trupanion (NASDAQ:TRUP) last posted its earnings results on Wednesday, February 19th. The financial services provider reported $0.04 earnings per share for the quarter, missing analysts’ consensus estimates of $0.06 by ($0.02). The company had revenue of $337.31 million during the quarter, compared to the consensus estimate of $335.41 million. Trupanion had a negative net margin of 0.75% and a negative return on equity of 3.11%. As a group, research analysts anticipate that Trupanion will post 0.13 earnings per share for the current fiscal year.

Insider Transactions at Trupanion

In other news, SVP Emily Dreyer sold 900 shares of the stock in a transaction that occurred on Monday, November 25th. The shares were sold at an average price of $54.55, for a total transaction of $49,095.00. Following the completion of the transaction, the senior vice president now directly owns 23,808 shares of the company’s stock, valued at $1,298,726.40. This represents a 3.64 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Fawwad Qureshi sold 9,867 shares of the firm’s stock in a transaction that occurred on Friday, November 29th. The stock was sold at an average price of $53.08, for a total transaction of $523,740.36. The disclosure for this sale can be found here. Insiders have sold 11,581 shares of company stock worth $615,159 in the last ninety days. Company insiders own 5.50% of the company’s stock.

Hedge Funds Weigh In On Trupanion

Institutional investors and hedge funds have recently bought and sold shares of the company. FMR LLC raised its stake in shares of Trupanion by 55,963.7% in the third quarter. FMR LLC now owns 1,172,293 shares of the financial services provider’s stock valued at $49,213,000 after buying an additional 1,170,202 shares during the period. Barclays PLC raised its stake in Trupanion by 259.2% in the 3rd quarter. Barclays PLC now owns 65,498 shares of the financial services provider’s stock valued at $2,750,000 after acquiring an additional 47,262 shares during the period. Centiva Capital LP purchased a new stake in Trupanion during the third quarter valued at about $595,000. FORA Capital LLC bought a new position in Trupanion during the third quarter worth about $540,000. Finally, Blueshift Asset Management LLC increased its stake in shares of Trupanion by 215.8% in the third quarter. Blueshift Asset Management LLC now owns 37,230 shares of the financial services provider’s stock worth $1,563,000 after purchasing an additional 25,440 shares in the last quarter.

About Trupanion

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.